| Reference |
Sentence |
Publish Date |
Extraction Date |
Species |
| Yao-Chen Zhang, Ke-Yi Fan, Qi Wang, Jing-Xi Hu, Qian Wang, He-Yi Zhang, Shan Song, Rong Zhao, Jun Qiao, Sheng-Xiao Zhan. Genetically Determined Levels of mTOR-Dependent Circulating Proteins and Risk of Multiple Sclerosis. Neurology and therapy vol issue 2023 36870011 |
results from observational studies indicate an association between circulating levels of mammalian target of rapamycin (mtor)-dependent circulating proteins and the risk of multiple sclerosis (ms). |
2023-03-04 |
2023-03-06 |
Not clear |
| Yang Yang, Wei Song, Ning Wang, Yuqing Ren, Hongzhuo Li. Tip-concentrated microneedle patch delivering everolimus for therapy of multiple sclerosis. Biomaterials advances vol 135 issue 2022 35929200 |
everolimus, as a new generation of mtor inhibitors, can effectively alleviate the inflammatory reaction of the central nervous system and offers a promising choice for the treatment of multiple sclerosis. |
2022-08-05 |
2023-01-30 |
Not clear |
| Aigli G Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, Maria Anagnostouli, Leonidas Stefanis, Panos Stathopoulo. The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International journal of molecular sciences vol 23 issue 15 2022 35897651 |
this article recapitulates the evidence on the role of mammalian targets of rapamycin (mtor) complex pathways in multiple sclerosis (ms). |
2022-07-28 |
2023-01-30 |
human |
| Aigli G Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, Maria Anagnostouli, Leonidas Stefanis, Panos Stathopoulo. The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International journal of molecular sciences vol 23 issue 15 2022 35897651 |
the mtor signaling pathway in multiple sclerosis; from animal models to human data. |
2022-07-28 |
2023-01-30 |
human |
| Aigli G Vakrakou, Anastasia Alexaki, Maria-Evgenia Brinia, Maria Anagnostouli, Leonidas Stefanis, Panos Stathopoulo. The mTOR Signaling Pathway in Multiple Sclerosis; from Animal Models to Human Data. International journal of molecular sciences vol 23 issue 15 2022 35897651 |
importantly, the study of mtor pathway contributions to autoimmune inflammatory demyelination and multiple sclerosis illustrates the difficulties in the clinical application of animal model results. |
2022-07-28 |
2023-01-30 |
human |
| Kenneth Maies. Novel Insights for Multiple Sclerosis and Demyelinating Disorders with Apoptosis, Autophagy, FoxO, and mTOR. Current neurovascular research vol 18 issue 2 2021 33964865 |
novel insights for multiple sclerosis and demyelinating disorders with apoptosis, autophagy, foxo, and mtor. |
2021-11-08 |
2023-01-26 |
Not clear |
| Fahimeh Akbarian, Mohammad Amin Tabatabaiefar, Vahid Shaygannejad, Mohammad Mahdi Shahpouri, Negin Badihian, Roshanak Sajjadi, Arezou Dabiri, Nazanin Jalilian, Mohammad Reza Noori-Daloi. Upregulation of MTOR, RPS6KB1, and EIF4EBP1 in the whole blood samples of Iranian patients with multiple sclerosis compared to healthy controls. Metabolic brain disease vol 35 issue 8 2021 32809098 |
upregulation of mtor, rps6kb1, and eif4ebp1 in the whole blood samples of iranian patients with multiple sclerosis compared to healthy controls. |
2021-09-02 |
2023-01-26 |
Not clear |
| Cinzia Dello Russo, Lucia Lisi, Douglas L Feinstein, Pierluigi Navarr. mTOR kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. Glia vol 61 issue 3 2013 23044764 |
mtor kinase, a key player in the regulation of glial functions: relevance for the therapy of multiple sclerosis. |
2013-07-03 |
2023-01-25 |
Not clear |